I agree it’s not great, especially as a holder, but that is a terribly superficial comment. It ignores the wider market and biotech sentiment. Go and look at some others.
RAC are now cashed up as been pointed out to you.
Following the SP as a marker of progress is absurd in this situation imo. I follow their progress against the planned activities.
They are doing pretty well.
If you’re a down ramper, get a new job. That was an appalling effort.
cheers
kk
Ann: Bonus Issue of Options - Letter to Eligible Shareholders, page-24
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.43 |
Change
0.060(4.40%) |
Mkt cap ! $245.3M | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.50 | $1.35 | $131.6K | 92.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2501 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 5038 | 1 |
View Market Depth
| Last trade - 14.52pm 06/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |